Alternative donor HSCT in refractory acquired aplastic anemia - Prevention of graft rejection and graft versus host disease by immunoablative conditioning and graft manipulation

Pediatric Transplantation

Volumn 16, Issue 6, 2012, Pages 577-581

  Urban, Christian ^a   Benesch, Martin ^a   Sovinz, Petra ^a   Sipurzynski, Sabine ^a   Lackner, Herwig ^a   Müller, Ewa ^a   Schwinger, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

alternative donor HSCT; children; conditioning; graft manipulation; refractory acquired aplastic anemia

Indexed keywords

CD34 ANTIBODY; OKT 3; THYMOCYTE ANTIBODY;

ADOLESCENT; APLASTIC ANEMIA; ARTICLE; ASPERGILLOSIS; CHILD; CLINICAL ARTICLE; ENGRAFTMENT; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMOLYTIC ANEMIA; HUMAN; INFLUENZA; KIDNEY FAILURE; LEUKOCYTE; MALE; PRESCHOOL CHILD; REFRACTORY ANEMIA; SCHOOL CHILD; SURVIVAL;

ADOLESCENT; ANEMIA, APLASTIC; ANTIGENS, CD19; ANTIGENS, CD3; ANTIGENS, CD34; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LIVING DONORS; MALE; PEDIATRICS; RENAL INSUFFICIENCY; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 84864615800     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01692.x     Document Type: Article

References (26)

1. Kurre P, Johnson FL, Deeg HJ,. Diagnosis and treatment of children with aplastic anemia. Pediatr Blood Cancer 2005: 45: 770-780. (Pubitemid 41416486)
2. Camitta BM, Thomas ED, Nathan DG, et al., Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality. Blood 1976: 48: 63-70.
3. Li FP, Alter BP, Nathan DG,. The mortality of acquired aplastic anemia in children. Blood 1972: 40: 153-162.
4. Camitta BM, Thomas ED, Nathan DG, et al., A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979: 53: 504-514. (Pubitemid 9140408)
5. Doney K, Leisenring W, Storb R, Appelbaum FR,. Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy. Ann Intern Med 1997: 126: 107-115. (Pubitemid 27058584)
6. Führer M, Rampf U, Baumann I, et al., Immunosuppressive therapy for aplastic anemia in children: A more severe disease predicts better survival. Blood 2005: 106: 2102-2104. (Pubitemid 41291726)
7. Kamio T, Ito E, Ohara A, et al., Relapse of aplastic anemia in children after immunosuppressive therapy: A report from the Japan Childhood Aplastic Anemia Study Group. Haematologica 2011: 96: 814-819.
8. Ohara A, Kojima S, Hamajima N, et al., Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood 1997: 90: 1009-1013. (Pubitemid 27314134)
9. Benesch M, Urban C, Sykora KW, et al., Transplantation of highly purified CD34 + progenitor cells from alternative donors in children with refractory severe aplastic anaemia. Br J Haematol 2004: 125: 58-63. (Pubitemid 38453278)
10. Urban C, Benesch M, Sykora KW, Schwinger W, Lackner H,. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia. Bone Marrow Transplant 2005: 35: 591-594. (Pubitemid 40450458)
11. Führer M, Burdach S, Ebell W, et al., Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): The SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. Klin Padiatr 1998: 210: 173-179. (Pubitemid 28361236)
12. Schumm M, Lang P, Taylor G, et al., Isolation of highly purified autologous and allogeneic peripheral CD34 + cells using the CliniMACS device. J Hematother 1999: 8: 209-218. (Pubitemid 29232643)
13. Schwinger W, Urban C, Lackner H, et al., Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34 + cells in three children with refractory severe aplastic anemia. Bone Marrow Transplant 2000: 25: 513-517. (Pubitemid 30137866)
14. Lang P, Schumm M, Greil J, et al., A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: Preliminary results of a pilot study. Klin Padiatr 2005: 217: 334-338. (Pubitemid 41746115)
15. Barfield RC, Otto M, Houston J, et al., A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation. Cytotherapy 2004: 6: 1-6. (Pubitemid 38325113)
16. Scheinberg P, Wu CO, Nunez O, Young NS,. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. J Pediatr 2008: 153: 814-819.
17. Pongtanakul B, Das PK, Charpentier K, Dror Y,. Outcome of children with aplastic anemia treated with immunosuppressive therapy. Pediatr Blood Cancer 2008: 50: 52-57. (Pubitemid 350234265)
18. Barker JN, Krepski TP, Defor TE, Davies SM, Wagner JE, Weisdorf DJ,. Searching for unrelated donor hematopoietic stem cells: Availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002: 8: 257-260. (Pubitemid 34619076)
19. Locasciulli A, Oneto R, Bacigalupo A, et al., Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: A report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2007: 92: 11-18. (Pubitemid 46232653)
20. Viollier R, Socié G, Tichelli A, et al., Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant 2008: 41: 45-50.
21. Yagasaki H, Takahashi Y, Hama A, et al., Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescents with acquired severe aplastic anemia. Bone Marrow Transplant 2010: 45: 1508-1513.
22. Sanders JE, Woolfrey AE, Carpenter PA, et al., Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. Blood 2011: 118: 1421-1428.
23. Kang HJ, Shin HY, Park JE, et al., Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study. Biol Blood Marrow Transplant 2010: 16: 1582-1588.
24. Eapen M, Le Rademacher J, Antin JH, et al., Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. Blood 2011: 118: 2618-2621.
25. Federmann B, Hägele M, Pfeiffer M, et al., Immune reconstitution after haploidentical hematopoietic cell transplantation: Impact of reduced intensity conditioning and CD3/CD19 depleted grafts. Leukemia 2011: 25: 121-129.
26. Meyers G, Maziarz RT,. Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia. Bone Marrow Transplant 2010: 45: 1479-1488.